SPANX-D Inhibitors
The inhibition of SPANX-D can be achieved through a variety of chemical compounds that target different aspects of cellular function. For instance, compounds that interfere with cell cycle progression, such as selective inhibitors of cyclin-dependent kinases, can indirectly suppress the activity of SPANX-D by arresting cells at specific checkpoints, thereby hindering the cellular proliferation with which SPANX-D is associated. Similarly, proteasome inhibitors contribute to the disruption of cell cycle and apoptosis pathways, leading to an environment that is less conducive to the expression of proteins like SPANX-D, which play a role in tumorigenesis. Furthermore, compounds that alter energy metabolism and DNA synthesis, such as those inhibiting ATP synthase or acting as alkylating agents, can diminish the proliferative capacity of cells, indirectly reducing the levels and functional activity of SPANX-D.
Additionally, modulation of gene expression through epigenetic mechanisms offers another avenue for the inhibition of SPANX-D. Histone deacetylase inhibitors, for example, can potentially alter the acetylation state of histones, thereby changing the expression profile of various genes, including SPANX-D. This change can lead to either the downregulation or silencing of SPANX-D, depending on the context of the cellular state and the specific inhibitor involved. In a similar vein, DNA methyltransferase inhibitors can lead to the demethylation and reactivation of previously silenced genes, which could conceivably result in a decrease in SPANX-D expression when hypermethylation is a regulatory mechanism.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A selective inhibitor of cyclin-dependent kinases 4 and 6. By impairing cell cycle progression, it indirectly inhibits SPANX-D, which is associated with cancer cell proliferation. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
An inhibitor of ATP synthase in mitochondrial membranes. It reduces cellular energy metabolism, which indirectly affects SPANX-D related processes by limiting energy-dependent cell proliferation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that modulates chromatin structure, potentially altering the expression of genes including SPANX-D by changing the acetylation state of histones. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that leads to the accumulation of regulatory proteins and the disruption of cell cycle progression and apoptosis pathways, affecting SPANX-D expression which is implicated in tumorigenesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that disrupts downstream signaling pathways involved in cell growth and proliferation, thereby indirectly inhibiting SPANX-D which is expressed in rapidly dividing cells. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
An alkylating agent that cross-links DNA, halting DNA replication and transcription, affecting SPANX-D expression that is involved in cell proliferation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to the demethylation and reactivation of silenced genes, potentially decreasing SPANX-D expression when hypermethylation is a regulatory mechanism. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A compound that regulates gene expression through retinoic acid receptors. It can modulate the expression of a variety of genes, including SPANX-D, by influencing differentiation and proliferation pathways. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glucose analog that inhibits glycolysis by competing with glucose, potentially affecting SPANX-D by disrupting the energy supply necessary for cell proliferation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A reversible proteasome and calpain inhibitor, leading to cell cycle arrest and apoptosis, which indirectly inhibits SPANX-D associated with cell survival and proliferation. | ||||||